Mobia Medical (NASDAQ:MOBI) Stock Rating Lowered by Wall Street Zen

Mobia Medical (NASDAQ:MOBI) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday.

A number of other research analysts have also recently commented on the stock. Wolfe Research began coverage on shares of Mobia Medical in a report on Tuesday. They issued an “outperform” rating for the company. JPMorgan Chase & Co. began coverage on shares of Mobia Medical in a report on Tuesday. They issued an “overweight” rating and a $15.00 target price for the company. Zacks Research raised shares of Mobia Medical to a “hold” rating in a report on Wednesday. BTIG Research began coverage on shares of Mobia Medical in a report on Tuesday. They issued a “buy” rating and a $19.00 target price for the company. Finally, Bank of America began coverage on shares of Mobia Medical in a report on Tuesday. They issued a “buy” rating and a $16.00 target price for the company. Five investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $20.25.

Mobia Medical Price Performance

MOBI stock opened at $12.62 on Friday. The stock has a market capitalization of $417.53 million, a PE ratio of 66.00 and a beta of 2.84. Mobia Medical has a 12 month low of $10.19 and a 12 month high of $14.77.

Mobia Medical (NASDAQ:MOBI) last posted its earnings results on Thursday, June 4th. The company reported $999.00 EPS for the quarter. The company had revenue of $12.07 million during the quarter.

Insiders Place Their Bets

In other Mobia Medical news, Director Casey M. Tansey acquired 66,666 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was acquired at an average price of $15.00 per share, for a total transaction of $999,990.00. Following the acquisition, the director directly owned 233,332 shares in the company, valued at $3,499,980. This represents a 40.00% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Cynthia L. Lucchese acquired 125,000 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was acquired at an average price of $15.00 per share, with a total value of $1,875,000.00. Following the acquisition, the director owned 125,000 shares in the company, valued at $1,875,000. The trade was a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have purchased 1,268,332 shares of company stock worth $19,024,980 over the last quarter.